Skip to Main Content

Author Details

Giovanni Parmigiani
Dana Farber Cancer Institute.
1997
241
69
PMIDPaper TitleJournal TitlePublished Year
37398422Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants.medRxiv2024
37398422Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants.medRxiv2024
36672340MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome.Cancers (Basel)2023
37885824Cross-Study Replicability in Cluster Analysis.Stat Sci2023
37786772Bayesian combinatorial MultiStudy factor analysis.Ann Appl Stat2023
36831433Combining Breast Cancer Risk Prediction Models.Cancers (Basel)2023
36945459Variant-specific Mendelian Risk Prediction Model.bioRxiv2023
36672340MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome.Cancers (Basel)2023
36603186High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.Blood2023
37786772Bayesian combinatorial MultiStudy factor analysis.Ann Appl Stat2023
37885824Cross-Study Replicability in Cluster Analysis.Stat Sci2023
36945459Variant-specific Mendelian Risk Prediction Model.bioRxiv2023
36831433Combining Breast Cancer Risk Prediction Models.Cancers (Basel)2023
36603186High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma.Blood2023
35292800Validity and Relative Validity of Alternative Methods of Assessing Physical Activity in Epidemiologic Studies: Findings From the Men's Lifestyle Validation Study.Am J Epidemiol2022
35583099Statistical methods for Mendelian models with multiple genes and cancers.Genet Epidemiol2022
36215697Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism.EMBO J2022
36274786Hierarchical resampling for bagging in multistudy prediction with applications to human neurochemical sensing.Ann Appl Stat2022
35997715A validation of models for prediction of pathogenic variants in mismatch repair genes.Genet Med2022
37873507PREDICTION OF HEREDITARY CANCERS USING NEURAL NETWORKS.Ann Appl Stat2022
36535935In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.Blood Cancer J2022
35292800Validity and Relative Validity of Alternative Methods of Assessing Physical Activity in Epidemiologic Studies: Findings From the Men's Lifestyle Validation Study.Am J Epidemiol2022
34854921Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.JAMA Oncol2022
37873507PREDICTION OF HEREDITARY CANCERS USING NEURAL NETWORKS.Ann Appl Stat2022
35583099Statistical methods for Mendelian models with multiple genes and cancers.Genet Epidemiol2022
36535935In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.Blood Cancer J2022
36274786Hierarchical resampling for bagging in multistudy prediction with applications to human neurochemical sensing.Ann Appl Stat2022
35997715A validation of models for prediction of pathogenic variants in mismatch repair genes.Genet Med2022
36215697Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism.EMBO J2022
34854921Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer: A US Nationwide Veterans Affairs Study.JAMA Oncol2022
33000511Statistical approaches for meta-analysis of genetic mutation prevalence.Genet Epidemiol2021
33991092covid19census: U.S. and Italy COVID-19 metrics and other epidemiological data.Database (Oxford)2021
33923159Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study.Vaccines (Basel)2021
33500320Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer.Cancer Epidemiol Biomarkers Prev2021
33245114Robustifying genomic classifiers to batch effects via ensemble learning.Bioinformatics2021
33030277Variation in cancer risk among families with genetic susceptibility.Genet Epidemiol2021
33120437A likelihood-based approach to assessing frequency of pathogenicity among variants of unknown significance in susceptibility genes.Stat Med2021
33000511Statistical approaches for meta-analysis of genetic mutation prevalence.Genet Epidemiol2021
34792571IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.Blood2021
35008209Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes.Cancers (Basel)2021
34703010A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO.Br J Cancer2021
34939926Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.Elife2021
33923159Influenza Vaccination and COVID-19 Mortality in the USA: An Ecological Study.Vaccines (Basel)2021
33500320Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer.Cancer Epidemiol Biomarkers Prev2021
35008209Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes.Cancers (Basel)2021
34939926Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays.Elife2021
34792571IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.Blood2021
34703010A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO.Br J Cancer2021
33991092covid19census: U.S. and Italy COVID-19 metrics and other epidemiological data.Database (Oxford)2021
33030277Variation in cancer risk among families with genetic susceptibility.Genet Epidemiol2021
  • 1 - 50 of 482

Recommended Authors

University of Kansas Medical Center
Career Start Year 2013
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 15
Brigham Young University
Career Start Year 2008
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 9
University of California san francisco
Career Start Year 2007
Number of shared co-authors 5
Chungnam National University
Career Start Year 2007
Number of shared co-authors 0
The Ohio State University
Career Start Year 2007
Number of shared co-authors 16
Department of Food Science and Technology, University of Nebraska-Lincoln
Career Start Year 2006
Number of shared co-authors 1
University of Washington
Career Start Year 2006
Number of shared co-authors 6
Duke University
Career Start Year 2005
Number of shared co-authors 11
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 9
Geisel School of Medicine at Dartmouth
Career Start Year 2004
Number of shared co-authors 3
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 6
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 26
TU Dortmund University
Career Start Year 2002
Number of shared co-authors 3
Keck School of Medicine, University of Southern California
Career Start Year 2001
Number of shared co-authors 3
Amsterdam University Medical Centers (Amsterdam UMC)
Career Start Year 2001
Number of shared co-authors 0
University of California los angeles
Career Start Year 2001
Number of shared co-authors 1
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 21
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 8
Yale University
Career Start Year 1995
Number of shared co-authors 2
Center for Cancer Genetic Epidemiology, University of Cambridge
Career Start Year 1994
Number of shared co-authors 34
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 6
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 6
University of California los angeles
Career Start Year 1991
Number of shared co-authors 4
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 11
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 14
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 22
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 20

Collaborators

Co-authored papers 27
Co-authored papers 25
Co-authored papers 23
City University of New York School of Public Health
Co-authored papers 14
Co-authored papers 13
Co-authored papers 12
Texas Children's Hospital
Co-authored papers 12
Johns Hopkins University School of Medicine
Co-authored papers 12
MD Anderson Cancer Center
Co-authored papers 11
Weill-Cornell School of Medicine
Co-authored papers 11
Co-authored papers 10
Dana-Farber Cancer Institute
Co-authored papers 10
Co-authored papers 10
Co-authored papers 9
Dana Farber Cancer Institute
Co-authored papers 9
Weill Medical College of Cornell University
Co-authored papers 8
Co-authored papers 8
Section of Clinical Nutrition and Nutrigenomic, University of Rome Tor Vergata
Co-authored papers 8
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 8
Harvard T.H. Chan School of Public Health
Co-authored papers 8
Broad Institute of MIT and Harvard
Co-authored papers 8
Co-authored papers 8
Georgetown University Medical Center
Co-authored papers 7
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers 7
Rollins School of Public Health, Emory University
Co-authored papers 6
Johns Hopkins University
Co-authored papers 6
Novartis Institutes for BioMedical Research
Co-authored papers 6
Co-authored papers 6
National Cancer Institute
Co-authored papers 5
Johns Hopkins School of Medicine
Co-authored papers 5